Menu
Recruiting NCT04145024

Giessen Pulmonary Hypertension Registry and Biobank

— Observational Pulmonary Hypertension

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Pulmonary Hypertension. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Germany
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Giessen Pulmonary Hypertension Registry and Biobank

Detailed description

Long-term transplant-free survival and its determinants will be investigated in patients with Pulmonary Hypertension (diagnosed by right heart catheterization) within a prospective registry at a single referral center in Giessen, Germany.

Primary outcome measures

  • Survival [Time frame: Up to 20 years after enrollment]

Eligibility criteria

Inclusion criteria

  • Right heart catheterization for PH diagnosis in Giessen

Exclusion criteria

  • informed consent missing

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Germany · 1 center
  • Department of Intermal Medicine - Universities of Giessen and Marburg Lung Center — Giessen

Publications

  • Gall H, Felix JF, Schneck FK, Milger K, Sommer N, Voswinckel R, Franco OH, Hofman A, Schermuly RT, Weissmann N, Grimminger F, Seeger W, Ghofrani HA. The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups. J Heart Lung Transplant. 2017 Sep;36(9):957-967. doi: 10.1016/j.healun.2017.02.016. Epub 2017 Feb 17. PMID 28302503

Identifiers

NCT: NCT04145024 · 2001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗